By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
Despite a Q1 earnings beat and raised guidance, Verisk's (VRSK) sluggish revenue growth and heavy reliance on cost-cutting raise concerns about its long-term growth prospects. The panelists agree that the stock's significant drawdown already embeds multiple compression assumptions, and a re-rating would require visible acceleration in organic revenue growth.
Risk: Lack of organic revenue acceleration and vulnerability to multiple compression if carriers pull back budgets or competitors erode pricing power
Opportunity: Potential re-rating if Verisk can demonstrate sustained organic revenue growth above 5-6%
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Jersey City, New Jersey-based Verisk Analytics, Inc. (VRSK) engages in the provision of data analytics and technology solutions to the insurance industry in the United States and internationally. Valued at a market cap of $22.4 billion, the company offers underwriting solutions, including forms, rules, and loss-cost services, such as policy language, prospective loss costs, policy writing, and other services.
VRSK shares have underperformed the broader market over the past year and in 2026. VRSK stock has declined 45.5% over the past 52 weeks and 23.7% on a YTD basis. In comparison, the S&P 500 Index ($SPX) has returned 25.1% over the past year and risen 8.6% in 2026.
Narrowing the focus, VRSK has also lagged behind the State Street Industrials Select Sector SPDR ETF’s (XLI) 18.8% rise over the past 52 weeks and its 10.1% increase this year.
On Apr. 29, VRSK stock rose 6.5% following the release of its Q1 2026 earnings. The company’s revenue rose 3.9% from the prior year’s quarter and came in at $782.6 million, surpassing the Street’s estimates. Moreover, its adjusted EPS amounted to $1.82, also coming in on top of Wall Street’s estimates. Verisk expects full-year earnings in the range of $7.45 to $7.75 per share, with revenue in the range of $3.19 billion to $3.24 billion.
For the current year, which ends in December, analysts expect VRSK’s EPS to rise 6.6% to $7.63 on a diluted basis. The company’s earnings surprise history is solid. It surpassed the consensus estimate in each of the last four quarters.
VRSK has a consensus “Moderate Buy” rating overall. Of the 20 analysts covering the stock, opinions include nine “Strong Buys,” one “Moderate Buy,” nine “Holds,” and one “Strong Sell.”
The configuration has remained the same over the last month.
On Apr. 30, JP Morgan analyst Andrew Steinerman maintained an "Overweight" rating for Verisk Analytics and raised its price target from $220 to $230.
VRSK’s mean price target of $222.53 indicates a modest premium of 30.4% from the current market prices. While the Street-high target of $275 suggests a notable 61.1% upside potential.
Four leading AI models discuss this article
"Anemic 3.9% revenue growth and 45% underperformance indicate structural headwinds that one earnings beat and analyst targets are unlikely to overcome."
VRSK's 45.5% 52-week decline versus the S&P 500's 25.1% gain signals deeper issues than one earnings beat can fix. Q1 revenue growth of just 3.9% to $782.6 million remains sluggish for a data-analytics firm tied to insurance, while full-year guidance of $3.19-3.24 billion implies only mid-single-digit expansion. The 20-analyst Moderate Buy rating and $222.53 mean target look detached from the reality of repeated underperformance against both the broad market and XLI. A single quarter's EPS beat of $1.82 does not reverse the trend of decelerating top-line momentum or explain the valuation compression already priced in.
The underperformance could simply reflect temporary insurance-cycle weakness that reverses once rates harden further, allowing the existing 6.6% EPS growth forecast and repeated estimate beats to drive re-rating toward the Street-high $275 target.
"VRSK is a mature, low-growth software company trading on multiple-expansion hope while fundamentals (3.9% revenue growth, 6.6% EPS growth) don't justify the 30% upside consensus assumes."
VRSK's Q1 beat and raised guidance mask a deeper problem: 3.9% revenue growth is anemic for a $22.4B software/analytics company, especially one claiming pricing power in insurance. The stock is down 45% YTD while SPX is up 25%—that's a 70-point gap that one quarter doesn't close. Adjusted EPS of $1.82 on $782.6M revenue implies heavy reliance on cost-cutting or buybacks, not organic expansion. The 6.6% EPS growth forecast for 2026 barely beats inflation. Analyst consensus is split (9 Holds vs. 9 Strong Buys), signaling genuine uncertainty. JPM's $230 target is only 4% above consensus—not conviction. The 30% upside to mean target assumes multiple expansion in a rising-rate environment where software multiples compress.
VRSK's consistent beat streak (4 straight quarters) and insurance industry tailwinds (pricing, M&A activity, regulatory complexity) could justify re-rating if growth inflects to 6-8% next quarter; the stock's 45% drawdown may have already priced in the slowdown.
"Verisk's significant year-over-year underperformance indicates the market is discounting the company's long-term growth prospects despite consistent earnings beats."
Verisk’s 45.5% drawdown is a massive red flag that suggests the market is pricing in structural decay rather than a cyclical dip. While the Q1 earnings beat is encouraging, a 3.9% revenue growth rate is sluggish for a company commanding a premium valuation. The 'Moderate Buy' consensus and 30% upside target feel like legacy optimism from analysts who haven't adjusted their models for a potential loss of pricing power in the insurance data market. Unless Verisk can accelerate organic growth through its AI-driven underwriting tools, the stock is likely a value trap that will continue to drift lower as investors rotate into higher-growth tech.
If Verisk's data moat is as impenetrable as management claims, the current valuation represents a rare entry point for a high-margin, recurring revenue business that is finally shedding its non-core assets to improve profitability.
"Verisk faces meaningful downside risk if insurance pricing cycles deteriorate, limiting upside even with steady earnings."
Bottom line: A Q1 beat and in-line full-year guide support resilience, not a disaster. But the beat is not a growth upgrade; 3.9% Q1 revenue growth and a mid-single-digit full-year outlook imply modest expansion, and a 2026 EPS rise around low- to mid-single digits. The article glosses over a key risk: Verisk’s cycle exposure to the underwriting market. A sustained soft or volatile insurance pricing cycle, plus budget-cuts at carriers, could sap demand for its risk analytics and underwriting solutions, limiting multiple upside even if earnings stay on track. In that case, valuation could compress even with steady results.
The strongest counterpoint is that Verisk is a sticky, high-quality platform with defensible margins; a Q1 beat and coherent guidance could trigger a sharp re-rating as investors realize the growth is durable, not just a one-off beat.
"Cycle tailwinds plus existing beats could force re-rating even with mid-single-digit revenue growth."
Gemini's structural decay narrative misses the direct tie between ChatGPT's insurance-cycle risk and Verisk's sticky analytics platform. A hardening rate environment would lift demand for underwriting tools without needing AI-led acceleration to 6-8% growth. The 45% drawdown already embeds multiple compression assumptions; any Q2 stabilization could trigger faster re-rating than the value-trap thesis allows, especially given four straight EPS beats.
"EPS beats without revenue inflection signal margin engineering, not durable growth—and cycle stabilization alone won't re-rate a stock already down 45%."
Grok conflates two separate scenarios: rate hardening lifting *demand* for underwriting tools versus VRSK's ability to *capture* that demand through pricing or volume. Four EPS beats don't prove growth inflection if they're driven by margin expansion (cost-cuts, mix shift) rather than top-line acceleration. ChatGPT's cycle risk is real—if carriers tighten budgets despite rate increases, VRSK's stickiness becomes irrelevant. The 45% drawdown may price in cycle weakness, but it doesn't guarantee re-rating once rates stabilize; that requires proof of organic revenue re-acceleration, not just stabilization.
"Verisk's inability to demonstrate operating leverage suggests the valuation multiple compression is a structural recalibration, not a temporary cyclical dip."
Claude, your focus on margin-driven EPS beats is the missing link. Everyone is obsessed with the top-line, but Verisk’s transition to a pure-play insurance data model has been a margin-expansion story, not a growth story. The real risk isn't just budget cuts; it’s the lack of operating leverage. If they can’t scale revenue faster than costs, the 'moat' is just a high-fixed-cost trap. The 45% drawdown is a valuation correction for a company that stopped acting like a growth stock.
"A margin-only EPS beat is not enough; Verisk needs a sustainable organic revenue inflection (>5-6% CAGR) to justify multiple expansion; otherwise risk of further multiple compression dominates."
Claude spots the right risk in margin-driven beats, but the more fragile link is top-line growth: 3.9% is mid-cycle, not a catalyst for re-rating. The hidden flaw is reliance on cost-cutting and mix to pad EPS while demand stays muted; that leaves Verisk vulnerable to multiple compression if carriers pull back budgets or if AI-enabled competitors erode pricing power. A re-rating hinges on visible accelerations in organic revenue >5-6% sustained.
Despite a Q1 earnings beat and raised guidance, Verisk's (VRSK) sluggish revenue growth and heavy reliance on cost-cutting raise concerns about its long-term growth prospects. The panelists agree that the stock's significant drawdown already embeds multiple compression assumptions, and a re-rating would require visible acceleration in organic revenue growth.
Potential re-rating if Verisk can demonstrate sustained organic revenue growth above 5-6%
Lack of organic revenue acceleration and vulnerability to multiple compression if carriers pull back budgets or competitors erode pricing power